Azucena Salas

Research group

Inflammatory bowel disease Group leader (R4)

asalas1@clinic.cat 0000-0003-4572-2907

Follow it on:

The Linkedin of Maria Azucena . This link opens in a new tab.

Featured publications

Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease

Authors: Ferrer-Picón E, Dotti I, Corraliza AM, Mayorgas A, Esteller M, Perales JC, Ricart E, Masamunt MC, Carrasco A, Tristán E, Esteve M, Salas A .

Reference: Inflammatory Bowel Diseases 2020.
Differences in peripheral and tissue immune cell populations following hematopoietic stem cell transplantation in Crohn's disease patients

Authors: Corraliza AM, Ricart E, López-García A, Carme Masamunt M, Veny M, Esteller M, Mayorgas A, Le Bourhis L, Allez M, Planell N, Visvanathan S, Baum P, España C, Cabezón-Cabello R, Benítez-Ribas D, Rovira M, Panés J, Salas A .

Reference: Journal Of Crohns & Colitis 2019.
An ROR gamma t Oral Inhibitor Modulates IL-17 Responses in Peripheral Blood and Intestinal Mucosa of Crohn's Disease Patients

Authors: Bassolas-Molina, Helena; Raymond, Ernest; Labadia, Mark; Wahle, Joseph; Ferrer-Picon, Elena; Panzenbeck, Mark; Zheng, Jie; Harcken, Christian; Hughes, Robert; Turner, Michael; Smith, Dustin; Calderdon-Gomez, Elisabeth; Esteller, Miriam; Carrasco, Anna; Esteve, Maria; Dotti, Isabella; Maria Corraliza, Ma; Carme Masamunt, Maria; Arajol, Claudia; Guardiola, Jordi; Ricart, Elena; Nabozny, Gerald; Salas, Azucena;.

Reference: Frontiers In Immunology 2018.
Usefulness of Transcriptional Blood Biomarkers as a Non-invasive Surrogate Marker of Mucosal Healing and Endoscopic Response in Ulcerative Colitis

Authors: Planell, Nuria; Carme Masamunt, M.; Franco Leal, Raquel; Rodriguez, Lorena; Esteller, Miriam; Lozano, Juan J.; Ramirez, Anna; Setsuko Ayrizono, Maria de Lourdes; Rodrigues Coy, Claudio Saddy; Alfaro, Ignacio; Ordas, Ingrid; Visvanathan, Sudha; Ricart, Elena; Guardiola, Jordi; Panes, Julian; Salas, Azucena;.

Reference: Journal Of Crohns & Colitis 2017.
Identification of inflammatory mediators in patients with Crohn''s disease unresponsive to anti-TNFalpha therapy

Authors: Leal, Raquel Franco; Planell, Nuria; Kajekar, Radhika; Lozano, Juan J; Ordas, Ingrid; Dotti, Isabella; Esteller, Miriam; Masamunt, M Carme; Parmar, Harsukh; Ricart, Elena; Panes, Julian; Salas, Azucena.

Reference: Gut 2015.
Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations

Authors: Planell, Nuria; Lozano, Juan J; Mora-Buch, Rut; Masamunt, M Carme; Jimeno, Mireya; Ordas, Ingrid; Esteller, Miriam; Ricart, Elena; Pique, Josep M; Panes, Julian; Salas, Azucena.

Reference: Gut 2013.

Featured Projects

Dissecting the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE) the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE)

Principal investigator: Maria Azucena Salas Martinez, Julian Panes Diaz

Funder: Ministerio de Ciencia, Innovación y Universidades (Programa financiador competitivo)

Code: RTI2018-096946-B-I00

Duration: 01/01/2019 - 31/12/2021
New siRNA Nanotherapy for Inflammatory Bowel Diseases, targeting Janus kinase 3

Principal investigator: Maria Azucena Salas Martinez

Funder: European Commission (Programa Horizon 2020). (Promotor)

Code: NEW DEAL

Duration: 02/01/2017 - 31/12/2020
Trasplante autólogo de células madre hematopoyéticas en la enfermedad de Crohn: factores moleculares, inmunes y microbiológicos implicados en el control de la enfermedad

Principal investigator: Maria Azucena Salas Martinez

Funder: Ministerio de Economía e Innovación. Comisión Interministerial de Ciencia y Tecnología. Secretaría General del Plan Nacional de I+D (Promotor)

Code: I+D SAF2015-66379

Duration: 01/01/2016 - 31/12/2018
Integrative analysis of the intestinal epithelium and the mucosal environment in pediatric versus adult onset Crohn’s Disease

Principal investigator: Maria Azucena Salas Martinez

Duration: 01/01/2019 - 31/12/2019
Cellular mechanisms in Crohn’s Disease: revealing new therapeutic avenues

Principal investigator: Maria Azucena Salas Martinez

Code: 2015PG-IBD005

Duration: 01/08/2014 - 01/08/2017

Azucena Salas

Research group

Featured publications

Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease

Differences in peripheral and tissue immune cell populations following hematopoietic stem cell transplantation in Crohn's disease patients

An ROR gamma t Oral Inhibitor Modulates IL-17 Responses in Peripheral Blood and Intestinal Mucosa of Crohn's Disease Patients

Usefulness of Transcriptional Blood Biomarkers as a Non-invasive Surrogate Marker of Mucosal Healing and Endoscopic Response in Ulcerative Colitis

Identification of inflammatory mediators in patients with Crohn''s disease unresponsive to anti-TNFalpha therapy

Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations

Featured Projects

Dissecting the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE) the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE)

New siRNA Nanotherapy for Inflammatory Bowel Diseases, targeting Janus kinase 3

Trasplante autólogo de células madre hematopoyéticas en la enfermedad de Crohn: factores moleculares, inmunes y microbiológicos implicados en el control de la enfermedad

Integrative analysis of the intestinal epithelium and the mucosal environment in pediatric versus adult onset Crohn’s Disease

Cellular mechanisms in Crohn’s Disease: revealing new therapeutic avenues

Subscribe to the Newsletter of Clínic